
|Articles|March 21, 2005
Combination acne drug showing good results
Connetics' investigational acne drug Velac—a once-a-day mixture of topical clindamycin and tretinoin in hydrogel—may be more convenient and at least as safe as either workhorse acne agent alone, say new studies. The findings could be hopeful news for the estimated 17 million or more Americans with acne. These results were reported at the American Academy of Dermatology annual meeting in New Orleans last month.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths
2
TrumpRx Promising Direct-to-Consumer Drugs for Discounted Prices
3
PCVs Significantly Reduce Pneumococcal Meningitis in Children
4
The Regimen: Pharmacists Bridging the Treatment Gap for Patients with OUD
5





































































































































